These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinical use of the fluorocarbon blood substitute perfluoran]. Krylov NL; Moroz VV; Beloiartsev FF Voen Med Zh; 1985 Aug; (8):36-40. PubMed ID: 3904195 [No Abstract] [Full Text] [Related]
6. [The effects of Fluosol-DA on the experimental myocardial infarction in dogs (author's transl)]. Hirooka Y; Kudo H; Suzuki A Kokyu To Junkan; 1979 Aug; 27(8):869-76. PubMed ID: 493741 [No Abstract] [Full Text] [Related]
7. Blood substitutes. Kostrzewska E Ann R Coll Surg Engl; 1976 Mar; 58(2):115-25. PubMed ID: 57736 [TBL] [Abstract][Full Text] [Related]
8. [Use of donor albumin and polyglucin as hemodynamic ingredients in perfluorocarbon emulsions]. Akhsianov UU; Sidliarov DP; Afonin NI Gematol Transfuziol; 1984; 29(5):53-5. PubMed ID: 6203809 [No Abstract] [Full Text] [Related]
9. [Efficacy of fluorocarbon (Fluosol-DA) on brain in low hematocrit conditions. Part 1: study on severely hemodiluted dogs by exchange transfusion (author's transl)]. Nagasawa S; Naruo Y; Oda Y; Murata T; Handa H Nihon Geka Hokan; 1979 Nov; 48(6):712-9. PubMed ID: 526098 [No Abstract] [Full Text] [Related]
10. New transfusion strategies: red cell substitutes. Winslow RM Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282 [TBL] [Abstract][Full Text] [Related]
11. [Current status of perfluorocarbons]. Welte M Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S165-8. PubMed ID: 11753732 [No Abstract] [Full Text] [Related]
12. [The corrective effect of perfluorocarbon emulsions on the cerebral hemodynamics in craniocerebral trauma]. Krivoshapkin AL; Krivoshapkin AL; Semenycheva TV Zh Vopr Neirokhir Im N N Burdenko; 1992; (6):17-9. PubMed ID: 1337408 [TBL] [Abstract][Full Text] [Related]
13. [Successive replacement of fatal blood loss in dogs with polyglucin and perfluorocarbon emulsion]. Akhsianov UU; Afonin NI Biull Eksp Biol Med; 1984 Aug; 98(8):160-2. PubMed ID: 6205706 [TBL] [Abstract][Full Text] [Related]
14. [Use of the human lymphoid Raji-line cell culture in tests of the toxicity of perfluorocarbon emulsions and their separate components]. Arkhipov VV; Narimanov AA Farmakol Toksikol; 1984; 47(5):117-20. PubMed ID: 6500028 [TBL] [Abstract][Full Text] [Related]
15. [Hematopoiesis in the dog in experiments with acute blood loss replaced by a PFC emulsion combined with polyglucin]. Fedorov NA; Gusenova FM; Afonin NI; Akhsianov UU; Kontuganov NN Patol Fiziol Eksp Ter; 1984; (5):3-7. PubMed ID: 6083530 [No Abstract] [Full Text] [Related]
16. Clinical use of a blood substitute. Honda K; Hoshino S; Shoji M; Usuba A; Motoki R; Tsuboi M; Inoue H; Iwaya F N Engl J Med; 1980 Aug; 303(7):391-2. PubMed ID: 7393252 [No Abstract] [Full Text] [Related]
19. Stable perfluorocarbon emulsions using XMO-10 as surfactant: potential oxygen-carrying plasma expanders. Jing N; Cooper BA Biomater Artif Cells Artif Organs; 1990; 18(1):107-17. PubMed ID: 2334810 [TBL] [Abstract][Full Text] [Related]
20. Oxygen transport in vivo by means of perfluorochemical preparations. Geyer RP N Engl J Med; 1982 Jul; 307(5):304-5. PubMed ID: 6806660 [No Abstract] [Full Text] [Related] [Next] [New Search]